- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloid Leukemia in United Kingdom
Total 6618 results
-
M.D. Anderson Cancer CenterIntrexon CorporationTerminatedAcute Myeloid Leukemia | Hematopoietic/Lymphoid CancerUnited States
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaWithdrawnSecondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Treatment-Related Acute Myeloid Leukemia | High-Risk Acute Myeloid LeukemiaUnited States
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Sanjay MohanNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingRecurrent Acute Myeloid LeukemiaUnited States
-
AbbVieActive, not recruitingCancer | Acute Myeloid Leukemia (AML)United States, Australia, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Switzerland, Taiwan, United Kingdom
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
University of UtahEisai Inc.CompletedAcute Myeloid Leukemia | AMLUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKlineRecruiting
-
Children's Hospital Medical Center, CincinnatiRecruitingAcute Myeloid LeukemiaUnited States
-
Nationwide Children's HospitalRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax PharmaceuticalsRecruiting
-
Uma BorateSuspended
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Jazz PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States, Spain, Canada, Israel, Korea, Republic of, Taiwan, France, Australia, Germany, Mexico, Japan, Sweden, China, Austria, Belgium, Czechia, Hungary, Italy, Poland, Romania, Russian Federation, United Kingdom
-
CephalonTerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Cellectis S.A.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Beat AML, LLCRecruitingPreviously Untreated Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
ALX Oncology Inc.Active, not recruitingA Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)Acute Myeloid Leukemia | AML, AdultUnited States
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteUnited States
-
CSL LimitedParexelCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Fred Hutchinson Cancer CenterTerminatedRecurrent Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Burkitt Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Acute Leukemia in Remission | Acute Undifferentiated Leukemia | Acute Biphenotypic Leukemia and other conditionsUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Hybrigenics CorporationUnknownAcute Myelogenous LeukemiaUnited States, France
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myeloid Leukemia | Recurrent Acute Myeloid LeukemiaUnited States
-
Polish Adult Leukemia GroupRecruiting
-
RAPT Therapeutics, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
University of Alabama at BirminghamRecruitingAcute Myeloid LeukemiaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); EFFECTOR Therapeutics, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
Guenther KoehneJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingAcute Myeloid LeukemiaUnited States
-
University of Colorado, DenverAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.SuspendedAcute Myeloid LeukemiaUnited States
-
Robert Redner, MDPfizerActive, not recruiting
-
University of Maryland, BaltimoreActive, not recruitingAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Carevive Systems, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
AbbVieActive, not recruitingAcute Myeloid Leukemia (AML)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Norway, Puerto Rico, Russian Federation, South Africa, Spain, T... and more
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; Taiho Oncology, Inc.RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States